Viatris Inc (VTRS) Stock Price, Quote & News

Latest News on VTRS

Jun 2, 2025, 1:12 PM EDT - 4 hours ago

SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Viatris

$Viatris Announces Positive Top-Line Results from Phase 3 LYNX-2 Trial of MR-142 in Keratorefractive Patients With Visual Disturbances Under Mesopic, Low-Contrast Conditions$

Jun 2, 2025, 8:00 AM EDT - 9 hours ago

Viatris Announces Positive Top-Line Results from Phase 3 LYNX-2 Trial of MR-142 in Keratorefractive Patients With Visual Disturbances Under Mesopic, Low-Contrast Conditions

May 31, 2025, 8:45 AM EDT - 2 days ago

SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Viatris

May 31, 2025, 7:07 AM EDT - 2 days ago

VTRS CLASS NOTICE: Viatris Inc. Investors may have been Affected by Fraud – Contact BFA Law before June 3 Court Deadline (NASDAQ:VTRS)

May 30, 2025, 9:06 AM EDT - 3 days ago

SHAREHOLDER REMINDER: Berger Montague Reminds Viatris (NASDAQ: VTRS) Investors of the June 3, 2025 Deadline

May 27, 2025, 10:38 AM EDT - 6 days ago

DEADLINE NEXT WEEK: Berger Montague Advises Viatris (NASDAQ: VTRS) Investors to Contact the Firm Before June 3, 2025

May 25, 2025, 7:42 AM EDT - 8 days ago

VTRS FRAUD: Suffer Losses on Viatris Inc.? You may have been Affected by Fraud and are Urged to Contact BFA Law (NASDAQ:VTRS)

May 23, 2025, 3:18 PM EDT - 10 days ago

VTRS FRAUD NEWS: Viatris Inc. is Being Sued for Securities Fraud; Investors That Lost Money Are Urged to Contact BFA Law by June 3 Court Deadline

May 22, 2025, 6:59 AM EDT - 11 days ago

Viatris to Participate in Upcoming Investor Conferences

May 21, 2025, 1:18 PM EDT - 12 days ago

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of June 3, 2025 in Viatris Lawsuit – VTRS

May 21, 2025, 8:46 AM EDT - 12 days ago

VTRS LAWSUIT: Lose Money on Viatris Inc.? Contact BFA Law before June 3 Court Deadline

May 14, 2025, 2:02 PM EDT - 19 days ago

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Viatris

May 14, 2025, 1:59 PM EDT - 19 days ago

Viatris Inc. (VTRS) BofA Securities 2025 Healthcare Conference (Transcript)

May 8, 2025, 2:55 PM EDT - 25 days ago

Viatris Discloses Positive Data From 2 Drugs In Earnings Report, Stock Soars

May 8, 2025, 12:41 PM EDT - 25 days ago

Viatris Q1 Earnings Review: Shares Are Up, Time To Sell (Rating Downgrade)

May 8, 2025, 10:35 AM EDT - 25 days ago

Viatris Inc. (VTRS) Q1 2025 Earnings Call Transcript

May 8, 2025, 8:19 AM EDT - 25 days ago

Viagra-maker Viatris beats quarterly estimates on demand for branded drugs in China

May 8, 2025, 6:59 AM EDT - 25 days ago

Viatris Reports First Quarter 2025 Results and Reaffirms 2025 Outlook

May 8, 2025, 6:45 AM EDT - 25 days ago

Viatris Announces Positive Results from Phase 3 Study of Investigational XULANE LO™ Low Dose Patch for Birth Control in Women of Childbearing Potential

May 8, 2025, 6:36 AM EDT - 25 days ago

Viatris' pain drug meets main goals of two late-stage trials

May 8, 2025, 6:30 AM EDT - 25 days ago

Viatris Announces Positive Top-Line Results from Two Pivotal Phase 3 Studies of Novel Fast-Acting Meloxicam (MR-107A-02) for the Treatment of Moderate-to-Severe Acute Pain

May 8, 2025, 5:45 AM EDT - 25 days ago

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of June 3, 2025 in Viatris Inc. Lawsuit - VTRS

May 7, 2025, 8:48 AM EDT - 26 days ago

VTRS SECURITIES UPDATE: Viatris Inc. Investors with Losses may have been affected by Fraud – Contact BFA Law by June 3 Court Deadline (NASDAQ:VTRS)

May 7, 2025, 6:59 AM EDT - 26 days ago

Market Cap	10.32B
Revenue (ttm)	14.74B
Net Income (ttm)	-634.20M
EPS (ttm)	N/A
PE Ratio	3.56
Forward PE	3.93
Profit Margin	-4.30%
Debt to Equity Ratio	1.02

Volume	12,063,878
Avg Vol	16,225,922
Day's Range	N/A - N/A
Shares Out	1.17B
Stochastic %K	79%
Beta	0.89
Analysts	Hold
Price Target	$11.18